Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Glimepiride I.P. 4mg + Metformin Hydrochloride I.P. 500mg Tablets
Therapeutic Category
Antidiabetic, Diabetic, Endocrinology
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*15
Price
₹129/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Gimtype M4 Tablet combines Glimepiride 4mg with Metformin Hydrochloride 500mg to effectively manage blood glucose levels in type 2 diabetes mellitus. Glimepiride stimulates pancreatic insulin secretion, while Metformin improves insulin sensitivity and reduces hepatic glucose production. This combination provides comprehensive glycemic control by targeting different mechanisms involved in diabetes.
Common side effects include hypoglycemia, nausea, gastrointestinal upset, dizziness, and in rare cases, lactic acidosis.
Indicated for the treatment of type 2 diabetes mellitus in patients requiring both improved insulin secretion and insulin sensitivity for optimal blood sugar control.
Take the medication with food to reduce stomach-related side effects. Regular monitoring of blood sugar and renal function is important. Not suitable for type 1 diabetes or diabetic ketoacidosis.
Store in a cool, dry place below 25°C. Protect from direct sunlight and moisture. Keep out of the reach of children.
Composition : Atorvastatin Calcium I.P. 10mg Tablets
Composition : Atorvastatin Calcium I.P. 20mg Tablets
Composition : Atorvastatin Calcium I.P. 40mg Tablets
Composition : Atorvastatin Calcium I.P. 80mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Clopidogrel I.P. 75mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Fenofibrate I.P. 160mg Tablets
Composition : Dapagliflozin 10mg + Metformin Hydrochloride I.P. 500mg Tablets
Composition : Dapagliflozin 10mg + Metformin Hydrochloride I.P. 1000mg Tablets
Composition : Dapagliflozin Propanediol Monohydrate 10mg + Vildagliptin I.P. 100mg Tablets
Composition : Metformin 1000mg (S.R.) Tablets
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This anti-diabetic combination is widely used in type 2 diabetes management, making it a strong prescription product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in type 2 diabetes, fasting and post-meal blood sugar control, insulin resistance, and long-term glycemic management. It is commonly prescribed by physicians and diabetologists, especially in patients requiring higher-dose combination therapy.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Glimepiride 4mg + Metformin Tablets with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from strong chronic prescription demand, long-term therapy usage, and steady monthly repeat sales in diabetes care when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this diabetic formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.